InvestorsObserver
×
News Home

Does Pharvaris NV (PHVS) Have What it Takes to be in Your Portfolio Monday?

Monday, December 19, 2022 12:19 PM | InvestorsObserver Analysts

Mentioned in this article

Does Pharvaris NV (PHVS) Have What it Takes to be in Your Portfolio Monday?

Pharvaris NV (PHVS) is near the top in its industry group according to InvestorsObserver. PHVS gets an overall rating of 77. That means it scores higher than 77 percent of stocks. Pharvaris NV gets a 94 rank in the Biotechnology industry. Biotechnology is number 49 out of 148 industries.

Overall Score - 77
PHVS has an Overall Score of 77. Find out what this means to you and get the rest of the rankings on PHVS!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Pharvaris NV Stock Today?

Pharvaris NV (PHVS) stock has risen 0.13% while the S&P 500 is lower by -0.54% as of 12:10 PM on Monday, Dec 19. PHVS has risen $0.01 from the previous closing price of $7.50 on volume of 126,949 shares. Over the past year the S&P 500 is lower by -16.12% while PHVS is lower by -54.21%. PHVS lost -$1.76 per share the over the last 12 months. Click Here to get the full Stock Report for Pharvaris NV stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App